Dr Andrew McMillan is a Consultant Haematologist at Nottingham University Hospitals NHS Trust and has a specialist interest in the treatment of lymphoma. He has previously Chaired the National Cancer Research Institute High Grade Lymphoma Subgroup. He has been Chief Investigator or UK lead on a number of NCRI and International clinical research protocols. He is also a member of the NCRI acute lymphoblastic leukaemia subgroup and the National Chemotherapy Clinical Reference group. He trained at University College Hospital and the Royal Free Hospital and has published papers and on Lymphoma, Acute Lymphoblastic Leukaemia and Autologous Stem cell Transplantation